Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2013, Article ID 865980, 9 pages
http://dx.doi.org/10.1155/2013/865980
Review Article

Genomic Biomarkers for Personalized Medicine: Development and Validation in Clinical Studies

Department of Data Science, The Institute of Statistical Mathematics, 10-3 Midori-cho, Tachikawa, Tokyo 190-8562, Japan

Received 26 January 2013; Accepted 22 March 2013

Academic Editor: Chuhsing Kate Hsiao

Copyright © 2013 Shigeyuki Matsui. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • D.C. Anderson, and Krishna Kodukula, “Biomarkers in pharmacology and drug discovery,” Biochemical Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Guang Hu, Yuqian Li, and Bairong Shen, “Identification of Biomarkers for Pharmacological Activity,” Bioinformatics for Diagnosis, Prognosis and Treatment of Complex Diseases, vol. 4, pp. 189–205, 2013. View at Publisher · View at Google Scholar
  • Yuan Zhang, Yue Cheng, Kebin Jia, and Aidong Zhang, “Opportunities for computational techniques for multi-omics integrated personalized medicine,” Tsinghua Science and Technology, vol. 19, no. 6, pp. 545–558, 2014. View at Publisher · View at Google Scholar
  • Florin-Dan Popescu, “Molecular biomarkers for grass pollen immunotherapy,” World Journal of Methodology, vol. 4, no. 1, pp. 26, 2014. View at Publisher · View at Google Scholar
  • Mahendra Rao, “National Institutes of Health: A Catalyst in Advancing Regenerative Medicine Science Into Practice,” Mayo Clinic Proceedings, vol. 90, no. 5, pp. 672–679, 2015. View at Publisher · View at Google Scholar
  • Kewal K. Jain, and Kewal K. Jain, “Role of Biomarkers in Personalized Medicine,” Textbook of Personalized Medicine, pp. 91–97, 2015. View at Publisher · View at Google Scholar
  • Miranta Antoniou, Andrea L. Jorgensen, and Ruwanthi Kolamunnage-Dona, “Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review,” Plos One, vol. 11, no. 2, 2016. View at Publisher · View at Google Scholar
  • Miranta Antoniou, Ruwanthi Kolamunnage-Dona, and Andrea Jorgensen, “Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review,” Journal of Personalized Medicine, vol. 7, no. 1, pp. 1, 2017. View at Publisher · View at Google Scholar
  • Joseph C. Cappelleri, Birol Emir, Demissie Alemayehu, and Josephine Sollanopp. 151–175, 2017. View at Publisher · View at Google Scholar
  • Atanu Bhattacharjee, Gajendra K. Vishwakarma, and Abin Thomas, “Bayesian State-Space Modeling in Gene Expression Data Analysis: An Application with Biomarker Prediction,” Mathematical Biosciences, 2018. View at Publisher · View at Google Scholar
  • Arinjita Bhattacharyya, and Shesh N. Rai, “Adaptive signature design- review of the biomarker guided adaptive phase –III controlled design,” Contemporary Clinical Trials Communications, pp. 100378, 2019. View at Publisher · View at Google Scholar